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SUMMARY
Cohesin subunits are frequently mutated in cancer,
but how they function as tumor suppressors is un-
known. Cohesinmediates sister chromatid cohesion,
but this is not always perturbed in cancer cells. Here,
we identify a previously unknown role for cohesin.
We find that cohesin is required to repress transcrip-
tion at DNA double-strand breaks (DSBs). Notably,
cohesin represses transcription at DSBs throughout
interphase, indicating that this is distinct from its
known role in mediating DNA repair through sister
chromatid cohesion. We identified a cancer-associ-
ated SA2 mutation that supports sister chromatid
cohesion but is unable to repress transcription at
DSBs. We further show that failure to repress tran-
scription at DSBs leads to large-scale genome rear-
rangements. Cancer samples lacking SA2 display
mutational patterns consistent with loss of this
pathway. These findings uncover a new function for
cohesin that provides insights into its frequent loss
in cancer.
INTRODUCTION
The cohesin complex is comprised of the core subunits SMC1A,
SMC3, RAD21, and either SA1 (STAG1) or SA2 (STAG2). When
bound to chromatin, cohesin associates with either the PDS5A
or PDS5B regulatory subunits. Following DNA replication, the
complex undergoes a transition along chromosome arms to
establish sister chromatid cohesion, which is dependent on the
acetyltransferases ESCO1 or ESCO2 (Dorsett and Stro¨m,
2012). Cohesion is promoted by the association of sororin with
acetylated SMC3, which prevents WAPL-mediated cohesin
removal (Ladurner et al., 2016). In mammalian cells, it has been
established that there is a division of labor between the cohesin
complexes working at different chromosomal locations. At
centromeres, cohesin complexes specifically contain SA2 and
PDS5B, and depend on ESCO2 for establishment of cohesion
(Canudas and Smith, 2009; Carretero et al., 2013; Remeseiro
et al., 2012; Whelan et al., 2012).
Mutation of genes encoding cohesin subunits, such as SA2,
is frequently observed in cancer. One obvious mechanism by
which cohesin could function as a tumor suppressor is through
preventing defects in chromosome segregation, which lead to
aneuploidy, by maintaining normal sister chromatid cohesion.
However, many cancers with mutations in SA2 do not display
obvious aneuploidy (Hill et al., 2016). In addition to its role medi-
ating sister chromatid cohesion, the cohesin complex is also
able to regulate transcriptional activity (Losada, 2014) and
is recruited to double-strand breaks (DSBs) to promote repair
in S and G2 phases of the cell cycle (Dorsett and Stro¨m, 2012).
Either or both of these activities could contribute to the tumor
suppressor activity of cohesin, but it is not yet clear whether or
to what degree they do.
In response to a DNA DSB, cells respond by repressing tran-
scription in the flanking chromatin (Shanbhag et al., 2010). This
pathway is dependent on ATM (Iannelli et al., 2017; Shanbhag
et al., 2010; Ui et al., 2015), and we found that the PBAF chro-
matin remodeling complex, one of two mammalian SWI/SNF
complexes, is also important for this activity and functions down-
stream of ataxia telangiectasia mutated (ATM) (Kakarougkas
et al., 2014).
Previously, we found that PBAF promotes sister chromatid
cohesion at centromeres (Brownlee et al., 2014). Because
both PBAF and cohesin are known to be recruited to DNA
DSBs, we hypothesized that cohesin may play a role together
with PBAF in repressing nearby transcription. Here, we
show that it does. Notably, we find that cohesin is required
for this pathway both in G1 and G2, demonstrating that this
is a distinct function from its known role in promoting DNA
repair through sister chromatid cohesion (Dorsett and Stro¨m,
2012; Gelot et al., 2016). In addition, we provide evidence
that the role of cohesin in repressing transcription contributes
to the maintenance of genome stability through preventing
large-scale genome rearrangements. Together, these find-
ings reveal a new function for the cohesin complex in the
cellular response to DNA DSBs that sheds light on its role in
tumorigenesis.
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Figure 1. Cohesin Contributes to Transcriptional Repression at DNA Double-Strand Breaks
(A) Cartoon of reporter construct (Tang et al., 2013) in which induction of themCherry-tagged FokI endonuclease results in double-strand break (DSB) induction in
a region upstream of a doxycycline-inducible reporter gene. Ongoing transcription of the reporter gene can be visualized by the presence of a YFP-MS2 fusion
protein that binds stem-loop structures in the nascent transcript.
(B, D, and H) Quantification of ongoing transcription in U2OS reporter cells (263 IFII) treated with small interfering RNA (siRNA) targeting SA2, PDS5B, BRG1, or
ARID2 (B), SMC3, Rad21, SA2, or BRG1 (D), or SA2, SA1, or PDS5A (H). NTC, non-targeting control. After addition of doxycycline to induce transcription (Tx),
transcriptional repression was monitored in cells with or without induction of the FokI endonuclease (DSB) by quantification of YFP-positive cells. Cells treated
(legend continued on next page)
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RESULTS
Cohesin Contributes to Transcriptional Repression at
DNA DSBs
To test whether cohesin is important for transcriptional repres-
sion in response to DNA breaks, we used an elegant reporter
cell line developed by Greenberg and colleagues in which
DSBs can be induced at a defined chromosomal location
upstream of an inducible reporter gene (Tang et al., 2013; Fig-
ure 1A). Ongoing transcription can be visualized by the presence
of a YFP-MS2 fusion protein that binds stem-loop structures in
the nascent transcript, and DNA DSBs are introduced by induc-
tion of an mCherry-tagged FokI endonuclease construct that
is targeted to a region upstream of the promoter (Shanbhag
et al., 2010; Tang et al., 2013).
Consistent with previous results, we found that transcriptional
repression in response to DSBs is dependent on ATM and
BRG1, which is the catalytic subunit of the PBAF chromatin
remodeling complex (Figures 1B, 1C, and S1; Kakarougkas
et al., 2014; Shanbhag et al., 2010). We also found that depletion
of the PBAF subunit BAF200 (ARID2) leads to a similar defect
(Figures 1B and 1C).
We tested the role of cohesin in this pathway and find that
depletion of the core cohesin subunits SMC3 or RAD21 leads
to defects in the ability of cells to repress transcription following
DNA damage (Figures 1D and 1E). In addition, we find that
depletion of SA2 and PDS5B, but not SA1 or PDS5A, leads to
similar defects (Figures 1B–1H).
To analyze this response using a different approach, we
monitored the incorporation of 5-ethynyl uridine (EU) following
laser microirradiation induced damage as a measure of ongoing
transcription (Figures 1I and S1). In control cells, quantification
shows a reduction in EU signal in damaged chromatin (Figure 1J).
Consistent with the known role in this pathway, loss of either the
BRG1 or ARID2 subunits of PBAF leads to a change in this
pattern that reflects more residual ongoing transcription (Figures
1I, 1J, and S1). In contrast, depletion of BRM, which is a subunit
of the BAF remodeling complex, has no effect on this pathway
(Figure 1J), suggesting that repression depends specifically on
PBAF. Similarly, depletion of SA2, but not SA1, results in more
EU incorporation in damaged chromatin than the control cells
(Figures 1I and 1J).
The ATM-dependent pathway leading to transcriptional
repression results in the accumulation of H2A K119 ubiquitina-
tion at sites of DNA damage (Shanbhag et al., 2010). Consis-
tently, we found PBAF is required for H2A K119ub after irradia-
tion (Kakarougkas et al., 2014; Figure S1E). We found that
irradiation-induced H2A K119ub is impaired following depletion
of SA2, but not SA1 (Figure S1E). We previously found that there
is a small but reproducible increase in gH2AX foci at early time
points following irradiation in the absence of PBAF subunits
(Kakarougkas et al., 2014), and here, we found a similar increase
in the absence of SA2, whereas SA1 depletion had no effect (Fig-
ure S1F). Together, these data demonstrate that the centromere-
specific cohesin complex subunits are important for mediating
transcriptional repression in response to DNA DSBs, and they
suggest that it is functioning in the same pathway as PBAF.
Transcriptional Repression near DNA Breaks Is
Dependent on PBAF and Cohesin in Both the G1 and G2
Phases of the Cell Cycle
Cohesin is known to facilitate repair by homologous recombina-
tion (Dorsett and Stro¨m, 2012; Losada, 2014). In addition, there is
evidence that it promotes accurate non-homologous end joining
(NHEJ) through use of the sister chromatid (Gelot et al., 2016).
Because these repair activities involve the sister chromatid, we
wondered whether the requirement for cohesin in mediating
transcriptional repression in response to a DNA DSB was also
restricted to the late S and G2 phases of the cell cycle when a
sister chromatid is present.
To investigate this, we first established that both SA2 and
BAF180 are recruited to laser-induced microirradiation (Figures
S2B–S2E). They appear to be independently recruited, as deple-
tion of BAF180 does not impact on SA2 accumulation and vice
versa (Figures S2J and S2K). Next, we examined whether these
proteins are recruited to damaged chromatin in different cell-
cycle stages by monitoring expression of an RFP-tagged Cdt1
construct (Figure S2A), which is expressed specifically in G1
phase (Sakaue-Sawano et al., 2008). Recruitment of BAF180
to laser induced microirradiation was the same in both G1-pos-
itive cells and cells outside of G1 (Figures 2A and 2B). Consistent
with a previous report (Caron et al., 2012), we also found that the
pattern of SA2 recruitment to damaged DNA was similar in cells
both in and outside of G1 (Figures 2C and 2D), supporting the
notion that cohesin is recruited to DSBs throughout interphase.
We then depleted PBAF and cohesin subunits and tested their
ability to repress transcription in response to a DSB in either G1
or G2 phase cells. Cell-cycle stage was monitored using CENPF
expression to identify cells in G2 and Cyclin D1 expression to
identify G1 positive cells. As expected in G2 cells, we found
that depletion of SA2 and BRG1 (but not depletion of SA1) led
to a loss of DSB-induced repression (Figures 2E and 2F). Impor-
tantly, we found that both SA2 and BRG1 are also required for
this activity in G1 cells (Figures 2G and 2H). In support of this,
with 10 mM ATM inhibitor are indicated (ATMi). 150 cells were analyzed per condition per repeat. Data are presented as the mean ± SD; n = 4 (B), n = 3 (D and H).
*p < 0.05, **p < 0.01 using Student’s t test.
(C, E, and G) Western blot analysis of whole-cell extracts prepared from cells treated with siRNA targeting SA2, PDS5B, BRG1, or ARID2 (C), SMC3 or Rad21 (E),
or SA2, SA1, or PDS5A (G). NTC, non-targeting control. a-Tubulin was used as a loading control.
(F) Representative images of U2OS reporter cells analyzed in (B). Arrow indicates location of FokI-induced DSB (mCherry) and/or YFP-MS2 transcript.
(I) Representative images of cells assayed for transcriptional activity by monitoring EU incorporation after DNA damage induced by laser microirradiation and
treatment with the indicated siRNA.
(J) Quantification of EU signal (new mRNA synthesis) across the path of laser micro-irradiation in cells treated as in (I). Data are presented as mean ± SEM.
A minimum of 30 cells were analyzed per repeat (n = 3–5 biological repeats).
See also Figure S1.
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Figure 2. Cohesin- and PBAF-Dependent Transcriptional Repression at DNA Double-Strand Breaks Occurs in Both G1 and G2 Phases
(A and C) Representative images of cells expressing GFP-BAF180 (A), GFP-SA2 (C), or Cdt1-RFP (to identify G1 phase cells) as indicated following laser
microirradiation.
(legend continued on next page)
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we also find that there is a reproducible increase in the number of
gH2AX foci in G1 cells at early time points following irradiation
when SA2 or BRG1 are depleted (Figure 2I).
These data demonstrate that the function of cohesin in the
transcriptional response to DNA DSBs is distinct from its known
role in promoting DNA repair through sister chromatid cohesion.
Cohesion Establishment and Cohesin Loading Factors
Are Important for Transcriptional Repression at DNA
DSBs in Both G1 and G2 Phases
We further investigated the genetic requirements related to co-
hesin function for this pathway. The recruitment of cohesin to
sites of DNA damage (Figure 2) suggests that the cohesin loader
might be involved, and it has recently been shown that the NIPBL
cohesin loader is recruited to DNA damage throughout the cell
cycle (Bot et al., 2017). We find that depletion of the cohesin
loader NIPBL leads to a defect in the ability of cells to repress
transcription at damaged DNA (Figures 3A, 3B, and S3C).
Notably, we also find that Sororin and ESCO2 are required
for transcriptional repression in response to a DNA break
and display a defect similar to that observed when either SA2
or PBAF subunits are depleted (Figures 3A–3E). In contrast, we
find that depletion of the negative regulator of cohesion,
WAPL, has no detectable impact on this pathway (Figures 3F
and 3G). We also found no effect on this pathway when CTCF
was depleted (Figures S3A and S3B).
(B and D) Quantification of GFP-BAF180 (B) or GFP-SA2 (D) recruitment to laser-microirradiation-induced damage in G1 cells (Cdt1-RFP positive) or cells outside
of G1 (Cdt1-RFP negative). Data represent the relative mean signal intensity ± SEM for n = 6 (B) or n = 7 (D) biological repeats. At least 42 cells were analyzed in
total for each construct per cell-cycle phase.
(E) Quantification of transcription in CENPF-positive (G2 phase) U2OS reporter cells treated with the indicated siRNA (NTC, non-targeting control) with or without
induction of the FokI endonuclease. Data are presented as the mean ± SD. More than 40 cells were analyzed per condition per repeat (n = 3 biological repeats).
(F) Representative images of U2OS reporter cells analyzed in (E).
(G) Quantification of transcription in cyclin-D1-positive (G1 phase) U2OS reporter cells treated with the indicated siRNAs. Data are presented as the mean ± SD.
More than 40 cells were analyzed per condition per repeat (n = 3 biological repeats).
(H) Representative images of U2OS reporter cells analyzed in (G).
(I) Quantification of gH2AX foci clearance following exposure to 1.5 Gy IR in G1 phase (cyclin D1 positive) U2OS cells treated with the indicated siRNA. Data are
presented as mean ± SD; n = 3 biological repeats.
*p < 0.05, **p < 0.01 using paired Student’s t test. See also Figure S2.
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Figure 3. Cohesin Establishment and
Loading Factors Are Important for Tran-
scriptional Repression at DNA DSBs in
Both G1 and G2 Phase Cells
(A, D, and F) Quantification of transcription in
asynchronous U2OS reporter cells with or without
induction of the FokI endonuclease (DSB) treated
with siRNA targeting Sororin, NIPBL, SA2, or
BRG1 (A), Esco2 (D), BRG1 or WAPL (F), and/or
with 10 mM ATM inhibitor (NTC, non-targeting
control). 150 cells were analyzed per condition,
per repeat. Data are presented as mean ± SD;
n = 3 (A), n = 4 (D), n = 4 (F) biological repeats.
(B, E, and G) Western blot analysis of whole-cell
extracts prepared from cells treated with siRNA
targeting NIPBL (B), Esco2 (E), or BRG1 or WAPL
(G). NTC, non-targeting control. a-Tubulin was
used as a loading control.
(C) qRT-PCR analysis of Sororin mRNA levels
following siNTC or siSororin treatment to provide
an indication of depletion efficiency.
(H) Quantification of transcription in cyclin-D1-
positive (G1 phase) U2OS reporter cells treated
with the indicated siRNAs. Data are presented as
the mean ± SD; n = 3 biological repeats.
(I) Quantification of transcription in CENPF-posi-
tive (G2 phase) U2OS reporter cells treated with
the indicated siRNA with or without induction of
the FokI endonuclease (DSB). More than 110 cells
were analyzed per condition, per repeat. Data are
presented as mean ± SD, n = 3 biological repeats.
*p < 0.05, **p < 0.01 using paired Student’s t test.
See also Figure S3.
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We next investigated whether these cohesin loading and
establishment factors are also required outside of S and G2
phases when no sister chromatid is present, and we found that
similar to the requirement for cohesin subunits, they are required
for the ability to repress transcription in response to DNA dam-
age in both G1 and G2 phase cells (Figures 3H and 3I).
ACancer-AssociatedMutant of SA2 that Is Proficient for
Sister Chromatid Cohesion Is Not Able to Repress
Transcription at DNA DSBs
It has been shown that mutation of the SA2 encoding gene
(STAG2) in cancer is not always associated with aneuploidy
(Balba´s-Martı´nez et al., 2013), suggesting that in at least some
cases, there is no defect in chromosome segregation as a result
of mutations in cohesin. In support of this, a recent mechanistic
study showed that a subset of cancer-associated SA2mutations
are proficient in mediating sister chromatid cohesion and chro-
mosome segregation (Kim et al., 2016). We tested the possibility
that these mutants might not be able to repress transcription
following DSBs.
To do this, we chose to study two point mutations that had
no obvious impact on protein stability, interaction with other
cohesin subunits, or sister chromatid cohesion (Kim et al.,
2016). These were V181M, identified in a myeloid leukemia,
and S202L from a bladder cancer. We introduced the mutations
into a GFP-tagged siRNA-resistant SA2 expression construct
(Figure S4). When we transfected the mutant or wild-type
expression constructs into cells that were depleted of endoge-
nous SA2 (Figure 4A), we found that the wild-type and V181M
constructs were able to rescue transcriptional repression after
DSB induction (Figures 4B and 4C). In contrast, the S202L
mutant construct was unable to rescue DNA DSB-induced
transcriptional repression (Figures 4B and 4C). These data
identify SA2-S202L as a separation of function mutation and
raise the possibility that this pathway might be important for
the ability of cohesin, and particularly SA2, to act as a tumor
suppressor.
PBAF and Cohesin Repress Large-Scale Chromosome
Rearrangements between Actively Transcribed Genes
If transcriptional repression at DSBs is important for preventing
tumorigenesis, it suggests that this pathway in some way
prevents genome instability. As a consequence of their three-
dimensional genome organization as well as their topological
and chromatin environment, actively transcribed genes are
vulnerable to translocations and large-scale genome rearrange-
ments (Osborne, 2014). Consequently, one possible function of
transcriptional repression following DSB induction is to prevent
mis-rejoining of DSBs within active genes leading to large-scale
genome rearrangements.
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To test the hypothesis that repression of transcription at DNA
breaks is important for the fidelity of repair, we set out to monitor
translocations between actively transcribed genes in a physio-
logically relevant system. For these studies, we chose the pros-
tate cancer cell line LNCaP, in which the androgen-responsive
gene TMPRSS2 and the ERG gene have been shown to undergo
translocations in an androgen- and DNA-damage-responsive
manner (Lin et al., 2009; Figures 5D and 5E), and this transloca-
tion event is frequently present in prostate cancers (Tomlins
et al., 2005). We find that androgen-induced TMPRSS2 tran-
scription is not substantially impaired in the absence of either
BAF180 or SA2 (Figures S5A and S5B), making this a good sys-
tem to investigate the DSB-induced transcriptional repression
pathway.
We began by investigating whether androgen-induced
expression of the TMPRSS2 gene is repressed after DNA dam-
age. First, we compared the expression levels in cells treated
with 5a-dihydrotestosterone (DHT) to activate transcription of
TMPRSS2 and compared this to DHT-treated cells that were
also irradiated. Treatment with ionizing radiation (IR) has previ-
ously been shown to result in the accumulation of DSBs at hot-
spots within the TMPRSS2 gene (Lin et al., 2009). These DSBs
are not directly produced by IR treatment but arise indirectly in
a damage- and androgen-dependent manner (Lin et al., 2009).
We found that transcription levels were lower in irradiated cells
than in unirradiated controls following induction with DHT (Fig-
ure 5A), consistent with transcriptional repression following
DSB induction. We also monitored transcription in cells treated
with DHT for 16 hr to reach steady-state transcription levels
and then irradiated the cells. Again, we found that transcription
levels decreased in response to IR, consistent with DSB-induced
transcriptional silencing (Figure S5C). Additionally, wemonitored
transcriptional activity in cells after depletion of ATM and found
that expression levels after damage remained the same as in
undamaged cells, consistent with a role for ATM in DSB-induced
transcriptional silencing (Figures 5B and 5C).
Next, we investigated the impact of loss of this pathway on the
formation of translocations between the TMPRSS2 and ERG
genes. We monitored translocation formation using a fluores-
cence in situ hybridization (FISH)-based assay (Ferna´ndez-Serra
et al., 2013; Figures 5D and 5E) or using qRT-PCR (Figures
S5D–S5F), and found, consistent with previous reports, an
increase after treating cells with DHT and IR (Figures 5F and
S5D). Notably, we found the number of translocations is further
increased when we depleted cells of ATM, the PBAF subunits
BAF180 or BRG1, or SA2 (Figures 5F–5H and S5D–S5F). In
contrast, depletion of SA1 did not lead to an increase in translo-
cation frequency (Figures 5F and 5H). These data support the
idea that the transcriptional repression of genes in the vicinity
of DNA breaks functions to prevent mis-rejoining of the broken
DNA ends and thus prevent genome rearrangements.
PBAF and Cohesin Are Important for Preventing
Chromosome Rearrangements in G1 Phase Cells,
Specifically When DSBs Are near Strong Transcriptional
Activity
To rule out known sister chromatid cohesion-dependent repair
functions, we monitored misrepair events following depletion
of SA2 or BAF180 in irradiated cells held in G1 phase, in which
no sister chromatid is present (Figures 6A, 6B, and S6A–S6E).
Cells held in G1 and depleted of SA2 or BAF180 were then
analyzed by differential exome sequencing (Figure 6B; Gelot
et al., 2016).
We found that control cells had an increased number of
large-scale genome rearrangements following irradiation (Fig-
ure 6B). Cells depleted of either BAF180 or SA2 similarly had
an increased number of large-scale rearrangements both with
and without irradiation (Figure 6B). These data suggest that
PBAF and cohesin function in the G1 phase of the cell cycle to
prevent misrepair of DNA DSBs.
We also treated irradiated SA2-depleted cells with 5,6-
Dichlorobenzimidazole 1-b-D-ribofuranoside (DRB) to globally
inhibit transcription (Figures S6A and S6B). We found that SA2
depletion under these conditions no longer resulted in an
increased number of genome rearrangements in irradiated G1
cells (Figure 6B), suggesting that the role of SA2 in preventing
genome instability in G1 is related to ongoing transcription.
We wanted to further investigate whether this role in prevent-
ing large-scale genome rearrangements is related to repressing
transcription at DNA DSBs. To do this, we used a modified pro-
tocol to measure translocations between the TMPRSS2 and
ERGgenes in which the DSBs are introduced at the translocation
breakpoints using CRISPR-Cas9 (Li et al., 2018; Figure 6C). This
way, DSB induction is no longer dependent on DHT-induced
transcription, allowing us to monitor translocation frequency un-
der conditions of different transcriptional activity levels.
We established that DHT treatment did not alter Cas9 expres-
sion (Figure S6F) and then monitored translocations using qRT-
PCR (Figure 6C). In control cells, introduction of Cas9 together
with the guide RNAs resulted in TMPRSS2:ERG rearrangements,
and the frequency was increased when the cells were treated
with DHT to induce TMPRSS2 transcription (Figure 6E), consis-
tent with the idea that actively transcribed genes are particularly
vulnerable to misrepair of DNA DSBs, leading to large-scale
rearrangements.
Depletion of SA2 resulted in an increase in translocations,
but only when cells were treated with DHT (Figures 6D and 6E),
suggesting that it is preventing misrepair only under conditions
of strong transcriptional activity. We found that depletion of
BAF180 similarly led to an increase in translocations in DHT-
treated cells, but not in untreated cells (Figures 6D and 6F). In
contrast, there was no increase under any conditions when
SA1 was depleted (Figures 6D and 6F). A small decrease in
translocations was apparent in these samples, but this may
have been due to lower levels of Cas9 expression when SA1
was depleted (Figure 6D).
Together, these data are in line with the idea that SA2 and
BAF180 repress transcription near DNA DSBs to promote their
accurate repair, and this happens throughout the cell cycle.
SA2-Deficient Cancers Show Distinct Patterns of
Genome Instability
Our data raise the possibility that SA2 (and the cohesin and
PBAF complexes) may contribute to preventing tumorigenesis
at least in part through their role in DSB-induced transcriptional
repression. We therefore investigated whether there was any
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Figure 5. Depletion of Cohesin or PBAF Leads to Increased Chromosome Rearrangements in the TMPRSS2 Gene Following Transcriptional
Induction and DNA Damage
(A and B) qRT-PCR analysis of relative TMPRSS2 transcript levels in LNCaP cells following transcriptional induction with 300 nM DHT (+DHT) and with or without
10 Gy irradiation after siRNA depletion with non-targeting control (NTC; A) or ATM (B). Data are presented as the mean ± SEM; n = 3 biological repeats.
(C) Western blot analysis of whole-cell extracts prepared from cells treated with siNTC or siATM. a-Tubulin was used as a loading control.
(D) Cartoon of gene organization and location of probes used in FISH assays to monitor TMPRSS2:ERG translocations. Following treatment with DHT and IR,
LNCaP cells underwent frequent rearrangements, as illustrated.
(E) Representative FISH images showing cells with (bottom) and without (top) TMPRSS2:ERG translocations (see D).
(F) Analysis of translocations between TMPRSS2 and ERG in LNCaP cells by FISH following transcription activation and DNA DSB induction in cells treated with
the indicated siRNA. 50 cells were analyzed per condition per repeat. Data are presented as the mean ± SEM, and a minimum of 3 (up to 12) biological repeats
were performed for each condition.
(G and H) Western blot analysis of whole-cell extracts prepared from LNCaP cells treated with siRNA targeting ATM, BAF180, or BRG1 (G) or ATM, SA2, or SA1
(H). NTC, non-targeting control. a-Tubulin was used as a loading control.
*p < 0.05, **p < 0.01 using unpaired Student’s t test. See also Figure S5.
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evidence for loss of this pathway in cancers lacking SA2. To look
at this, we analyzed sequencing data from bladder cancer,
where there are substantial numbers of available samples with
and without mutations in the SA2-encoding gene.
By performing non-negative matrix factorization (NNMF) of the
sequences (as in Polak et al., 2017), we identified 5 signatures
associated with SA2-proficient cancers and 5 signatures
associated with SA2-deficient cancers (Figure 7A; Table S1).
When compared with the existing mutational signatures defined
by Nik-Zainal and colleagues (Alexandrov et al., 2015; Nik-
Zainal et al., 2012), these signatures clustered into 6 clusters, of
which 3 overlapped (Figure 7B; Table S1). These overlapping sig-
natures included signature 1, which is found in all cancers, and
signatures 2 and 13,which are thought to be related to the activity
of the AID/APOBECcytidine deaminases and are frequently seen
in bladder cancer. Signature 10 was also evident in both groups.
The signatures unique to the bladder cancers without SA2muta-
tions are 15, which is associated with defective mismatch repair,
and 16, which has an unknown etiology. The signature that is
unique to the SA2-deficient cancers is signature 3 (Table S1),
which is associated with defective homologous recombination
(HR). Thus, we show that loss of cohesin leads to defective HR,
as predicted from its known role in this pathway.
Based on our experimental data, we would predict that
the absence of DNA DSB-induced transcriptional repression
should additionally lead to increased large-scale rearrange-
ments. Unfortunately, there is little available large-scale
chromosomal rearrangement data for bladder cancer. How-
ever, copy-number variation (CNV) data are available, and
CNV can arise through pathways that include large-scale
mis-rejoining events and genome rearrangements (Hastings
et al., 2009).
We therefore looked at the changes in copy number using
segment mean data in order to interrogate large-scale genome
rearrangements, such as duplications and large deletions. We
find that there are significantly more segment mean changes
in SA2-deficient cancers than in SA2-WT (wild-type) cancers
(Figure 7C), consistent with the data we generated in our exper-
imental systems (Figures 5 and 6).
Together with the analysis of the cancer-associated S202L
mutation of SA2, which is proficient for sister chromatid cohe-
sion, but not transcriptional repression at DNA breaks (Figure 4),
these data raise the possibility that one mechanism by which
SA2 functions as a tumor suppressor gene is through its role in
promoting accurate repair at DNA DSBs that occur in the vicinity
of actively transcribed genes.
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Figure 6. PBAF and Cohesin Are Important
for Preventing Chromosome Rearrange-
ments at DSBs in G1, Specifically at DSBs
near Strong Transcriptional Activity
(A) Western blot analysis of cell extracts pre-
pared from G1-arrested U2OS cells. Cells were
depleted of the indicated factors (NTC, non-tar-
geting control) and harvested 6 hr after irradiation
with 0 or 10 Gy. DRB was used for 1 hr prior to
irradiation in the SA2-depleted cells to inhibit
transcription. a-Tubulin was used as a loading
control.
(B) Table of large-scale genome rearrangements
identified in BAF180- or SA2-depleted G1 phase
cells treated as in (A) using differential exome
sequencing. UT, untreated. DRB was used for 1 hr
prior to irradiation in the SA2-depleted cells to
inhibit transcription.
(C) Schematic illustrating the CRISPR-Cas9 sys-
tem for generating DNA DSBs in the TMPRSS2
and ERG genes. Guide RNA positions are indi-
cated (Cas9-guideTMPRSS2 and Cas9-guide-
ERG). Translocation between these genes is
monitored by qRT-PCR using a forward primer
that flanks the fusion and a reverse primer that
recognizes the ERG gene.
(D) Western blot analysis of whole-cell
extracts prepared from LNCaP cells trans-
fected with the indicated siRNAs and FLAG-
tagged Cas9 with or without the TMPRSS2
and ERG guide RNAs (Cas9-guideT/E or
Cas9-no guide) in the presence or absence of
300 nM DHT.
(E and F) Relative TMPRSS2:ERG translocation
frequency monitored by qRT-PCR as outlined in
(C) in cells treated as in (D). Cells were treated with siRNA targeting SA2 (E), or BAF180 or SA1 (F). NTC, non-targeting control. Data are presented as the mean ±
SD; n = 6 (E) n = 3 (F) biological repeats. *p < 0.05, **p < 0.01 using unpaired Student’s t test. NS, not significant.
See also Figure S6.
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DISCUSSION
Here, we identify a new function for the cohesin complex.
We find the centromere-specific cohesin complex subunits,
including SA2, are required for repressing transcription near to
DNA breaks. While our data suggest that cohesion establish-
ment factors contribute to this activity, we find that this takes
place in both G1 and G2 phases of the cell cycle and is therefore
not dependent on the presence of a sister chromatid. This is a
distinct function from its known roles in promoting repair by
HR and by using sister chromatid cohesion to promote accurate
NHEJ (Gelot et al., 2016).
We find that failure to repress transcription near DNA DSBs
can lead to large-scale genome rearrangements, such as trans-
locations. One mechanism by which repressing transcriptional
activity could help to prevent these rearrangements is by
providing unobstructed access to the repair machinery. The
RNA polymerase may disrupt tethering of the broken DNA
ends, leading to an increased possibility of misrepair. In addition,
since actively transcribed genes are preferentially repaired by
HR (at least in S and G2 phase cells; Aymard et al., 2014), the
transcription machinery could impede resection and/or strand
invasion, which require long stretches of chromatin. While we
Figure 7. SA2-Deficient Bladder Cancer
Samples Show Patterns of Genome Insta-
bility that Are Consistent with Loss of Cohe-
sin-Mediated Repair Functions
(A) Mutational spectra of all base substitutions
observed in SA2-wild-type (top) and SA2 mutant
(bottom) bladder cancer samples. Five signatures
were identified in each group. See Table S1 for
details.
(B) Heatmap showing the correlation between the
mutational signatures identified in the SA2-strati-
fied bladder cancer samples and those published
in COSMIC (Alexandrov et al., 2015). The SA2
mutant cancers (but not the wild-type [WT]
bladder cancer samples) had a signature matching
COSMIC signature 3, which is annotated as a loss
of homologous recombination.
(C) Copy-number variation measured as a per-
centage of segment mean changes present in SA2
mutant or wild-type bladder cancer samples. The
SA2 mutant samples had an average of 482 genes
with a gain or loss due to copy-number changes,
whereas the samples without SA2 mutation had an
average of 310. The null hypothesis was that the
mutation status of SA2 was independent of the
number of genes that had a changed segment
mean. ***p < 0.001 using chi-squared test.
See also Table S1.
find a role for this pathway throughout
interphase, it is possible that the conse-
quences of its loss are greater in S and
G2 phases, when HR is available.
We show that cohesin loading and
establishment factors are required for re-
pressing transcription near DNA breaks,
and this is true in G1 and G2 phase cells.
Cohesin may be looping the DNA in areas proximal to the break
in order to reorganize the chromosome region. This could not
only directly impact transcription but also remove the broken
DNA end from the vicinity of other actively transcribed genes
to prevent misrepair.
Our data suggest that SA2, but not SA1, is required for repres-
sing transcription near DNA breaks. Recently, SA2 has been
shown to bind to DNA structures such as double-stranded
DNA ends, single-stranded overhangs, flaps, and single-
stranded DNA (ssDNA) gaps (Countryman et al., 2018), suggest-
ing one mechanism by which it could specifically function in this
pathway. In addition, it was recently found that SA2 and SA1
play distinct roles in genome organization (Kojic et al., 2018).
Specifically, SA2 appears to associate more dynamically with
chromatin and has a greater role in mediating gene expression
than SA1, which contributes more to topological organization
of the genome (Kojic et al., 2018). These properties of SA2
make it well suited to be employed as part of the DNA damage
response, associate with damaged chromatin, and regulate the
expression of nearby genes.
Cohesin plays multiple cellular roles, many of which can
impact on genome stability and cellular identity. Consequently,
the mechanisms by which the cohesin complex acts to prevent
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tumorigenesis are an outstanding question in the field (Hill et al.,
2016). While defective sister chromatid cohesion leading to
aneuploidy could drive cancer progression, it is clear that this
is not the mechanistic explanation in all cases. There is also ev-
idence thatmisregulation of transcription in the absence of cohe-
sin plays a role in at least some cancers (Mazumdar et al., 2015).
In addition, cohesin makes multiple contributions to DNA repair
(Brough et al., 2012; Gelot et al., 2016; Kong et al., 2014), and our
analysis of mutational signatures associated with loss of SA2
(Figure 7) suggests that HR deficiency may be a contributing
factor to tumorigenesis in these cells. Here, we provide evidence
that transcriptional repression in response to nearby DNA
DSBs also contributes to genome stability. This function is an
important component of cohesin’s suite of functions that may
contribute to its role in preventing tumorigenesis.
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REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Mouse monoclonal anti-ARID2 (E-3) Santa Cruz sc-166117; RRID: AB_2060382
Rabbit monoclonal anti-ATM (D2E2) Cell Signaling Technology 2873; RRID: AB_2062659
Rabbit polyclonal anti-Baf180 Millipore ABE70; RRID: AB_10807561
Rabbit polyclonal anti-BMI1 Bethyl Labs A301-694A; RRID: AB_1210891
Mouse monoclonal anti-BRG1 (G7) Santa Cruz sc-17796; RRID: AB_626762
Rabbit polyclonal anti-CENPF Bethyl Labs A301-611A; RRID: AB_1210906
Rabbit polyclonal anti-CTCF Millipore 07-729; RRID: AB_441965
Rabbit polyclonal anti-Cyclin D1 Neomarkers RB-010-PO
Rabbit polyclonal anti-Esco2 Abcam ab86003; RRID: AB_1924967
Rabbit monoclonal anti-EZH2 Cell Signaling Technology 5246; RRID: AB_10694683
Mouse monoclonal anti-GFP (B2) Santa Cruz sc-9996; RRID: AB_627695
Mouse monoclonal anti-H2A-K119ub (E5C5) Millipore 05-678; RRID: AB_309899
Rat monoclonal anti-NIPBL Abcam ab106768; RRID: AB_10859516
Rabbit polyclonal anti-PDS5A Abcam ab122352; RRID: AB_11129705
Rabbit polyclonal anti-PDS5B Abcam ab70298; RRID: AB_1269710
Rabbit polyclonal anti-Rad21 Abcam ab992; RRID: AB_2176601
Rabbit polyclonal anti-SMC3 Abcam ab155587
Goat polyclonal anti-SA1 Abcam ab4457; RRID: AB_2286589
Goat polyclonal anti-SA2 Abcam ab4463; RRID: AB_304471
Rabbit polyclonal anti-WAPL Abcam ab70741; RRID: AB_2216719
Mouse monoclonal anti-a-tubulin Abcam ab7291; RRID: AB_2241126
Mouse monoclonal anti-g-H2AX (pSer139) (JBW301) Millipore 05-636; RRID: AB_309864
Goat Anti-Rabbit Immunoglobulins/HRP Agilent (Dako) P044801-2
Rabbit Anti-Mouse Immunoglobulins/HRP Agilent (Dako) P026002-2; RRID: AB_2636929
Rabbit Anti-Goat Immunoglobulins/HRP Agilent (Dako) P044901-2
Goat Anti-Rat Immunoglobulins/HRP Millipore AP136P; RRID: AB_91300
Goat Anti-Mouse IgG/FITC Sigma-Aldrich F0257-1ML
Sheep Anti-rabbit IgG/Cy3 Sigma-Aldrich C2306-1ML
Goat Anti-Mouse IgG/Alexa Fluor 555 Thermo Fisher Scientific (Invitrogen) A-21422; RRID: AB_141822
Chemicals, Peptides, and Recombinant Proteins
4-hydroxytamoxifen Sigma-Aldrich H7904-5MG
5,6-Dichlorobenzimidazole 1-b-D-ribofuranoside (DRB) Sigma-Aldrich D1916-10MG
ATM Kinase Inhibitor Santa Cruz Biotechnology sc-202963 (CAS 587871-26-9)
cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail Sigma-Aldrich
(Roche Applied Science)
04693159001
5a-Dihydrotestosterone (DHT) Sigma-Aldrich D-073-1ML
Doxycycline hyclate Sigma-Aldrich D9891-G
Hoechst 33258 solution Sigma-Aldrich 94403-1ML
Propidium iodide Thermo Fisher Scientific (Invitrogen) P3566
RNase A Sigma-Aldrich R5503-100MG
Sheild1 Clontech Laboratories UK Ltd 632189
Thymidine Sigma-Aldrich T1895-5G
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Critical Commercial Assays
Click-iT RNA Alexa Fluor 594 Imaging Kit Thermo Fisher Scientific (Invitrogen) C10330
HiPerFect Transfection Reagent QIAGEN 301705
Lipofectamine RNAiMAX Transfection Reagent Thermo Fisher Scientific (Invitrogen) 13778150
Lipofectamine LTX Reagent with PLUS Reagent Thermo Fisher Scientific (Invitrogen) 15338100
Nucleospin Tissue Machery-Nagel 740952.5
Power SYBR green PCR master mix Thermo Fisher Scientific
(Applied Biosystems)
4367659
Premo FUCCI Cell Cycle Sensor (BacMam 2.0) Thermo Fisher Scientific (Invitrogen) P36237
QIAGEN RNeasy Mini Kit QIAGEN 74106
QuikChange II Site-Directed Mutagenesis Kit Agilent 200523
SuperScript First-Strand Synthesis System for RT-PCR Thermo Fisher Scientific (Invitrogen) 11904018
TurboFect Transfection Reagent Thermo Fisher Scientific R0531
TMPRSS2/ERG Deletion/Breakapart Probe Cytocell LPS 021
Deposited Data
Differential exome sequencing data and files This paper SAMN08226046
Human reference genome NCBI build 37, GRCh37 Genome Reference Consortium https://www.ncbi.nlm.nih.gov/
projects/genome/assembly/
grc/human/
Genomic data commons Grossman, 2016 N/A
COSMIC database Forbes et al., 2017 https://cancer.sanger.ac.uk
Raw data files deposited in Mendeley Data This paper https://doi.org/10.17632/
4h486ty62f.1
Experimental Models: Cell Lines
U2OS From cell line stocks at GDSC,
Sussex University, validated by
STR profiling with ECACC
N/A
U2OS 263 IFII Gift from Roger Greenberg;
Tang et al., 2013
N/A
U2OS 265 Gift from Roger Greenberg;
Tang et al., 2013
N/A
LNCaP clone FGC ATCC CRL-1740
U2OS Baf180 KO CRISPR Clone 15 This paper N/A
U2OS NTC sh Hopkins et al., 2016 N/A
U2OS Baf180 sh Hopkins et al., 2016 N/A
Oligonucleotides
siRNA sequence: ARID2 SMARTpool: ON-TARGETplus Dharmacon L-026945-01-0005
siRNA sequence: Baf180 SMARTpool: ON-TARGETplus Dharmacon L-008692-01-0005
siRNA sequence: BRG1 SMARTpool: ON-TARGETplus Dharmacon L-010431-00-0005
siRNA sequence: BRM SMARTpool: ON-TARGETplus Dharmacon L-017253-00-0005
siRNA sequence: CTCF SMARTpool: ON-TARGETplus Dharmacon L-020165-00-0005
siRNA sequence: Esco2 SMARTpool: ON-TARGETplus Dharmacon L-025788-01-0005
siRNA sequence: NIPBL SMARTpool: ON-TARGETplus Dharmacon L-012980-00-0005
siRNA sequence: NTC: Non-targeting pool: ON-TARGETplus Dharmacon D-001810-10-20
siRNA sequence: Rad21 SMARTpool: ON-TARGETplus Dharmacon L-006832-00-0005
siRNA sequence: SMC3 SMARTpool: ON-TARGETplus Dharmacon L-006834-00-0005
siRNA sequences for ATM, NTC, PDS5A, PDS5B, Sororin, STAG1,
STAG2, WAPL, see Table S4
This paper N/A
Primer: TMPRSS2_rtPCR FWD: CTGGTGGCTGATAGGGGAT Lin et al., 2009 N/A
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Further information and requests for resources and reagents should be directed to andwill be fulfilled by the LeadContact, Jessica A.
Downs (Jessica.Downs@icr.ac.uk).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Lines and Cell Culture
The U2OS, U2OS Baf180 KO and Baf180sh, and U2OS reporter cell lines (U2OS 263 IFII and U2OS 265, Tang et al., 2013) were
maintained in a 5% CO2 incubator at 37
C in GIBCO DMEM media (Life Technologies, Paisley, UK) supplemented with 100 U/mL
penicillin/streptomycin, 2 mM L-glutamine and 10% FCS (U2OS) or 10% TET System approved FCS (U2OS reporter cell lines;
631106, Takara Bio).
LNCaP cells were obtained from ATCC (Clone FGC, CRL-1740) and cultured in GIBCO RPMI media (Life Technologies, Paisley,
UK) supplemented with 10% FCS, 2 mM L-glutamine, 100 U/mL penicillin/streptomycin, 10 mMHEPES and 1 mM sodium pyruvate.
All cell lines were regularly tested for mycoplasma contamination.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Primer: TMPRSS2_rtPCR REV: GTCTGCCCTCATTTGTCGAT Lin et al., 2009 N/A
Primer: TMPRSS2-CR-3F: CACCGTTCATTCACGATCCCTAACA Li et al., 2018 N/A
Primer: TMPRSS2-CR-3R: AAACTGTTAGGGATCGTGAATGAAC Li et al., 2018 N/A
Primer: ERG-CR-2F: CACCGGGATGGTAAACGGAGAGTGC Li et al., 2018 N/A
Primer: ERG-CR-2R: AAACGCACTCTCCGTTTACCATCCC Li et al., 2018 N/A
Primer: TMPRSS2:ERG FWD: AGCGCGGCAGGAAGCCTTAT Sigma N/A
Primer: TMPRSS2:ERG REV: CCGTAGGCACACTCAAACAACGA Mani, 2016 N/A
Primer: Reporter Transcript FWD: TCATTAGATCCTGAGAACTTCA Shanbhag et al., 2010 N/A
Primer: Reporter Transcript REV: TTTTGGCAGAGGGAAAAAGA Shanbhag et al., 2010 N/A
Primer: Actin_rtPCR FWD: GCTCGTCGTCGACAACGGCTC Lin et al., 2009 N/A
Primer: Actin_rtPCR REV: CAAACATGATCTGGGTCATCTTCTC Lin et al., 2009 N/A
Primer: cyclophilin A_rtPCR FWD: CTGGACCCAACACAAATGGT This paper N/A
Primer: cyclophilin A_rtPCR REV: GCCTTCTTTCACTTTGCCAAAC This paper N/A
Primer: Sororin_rtPCR FWD: AGTCTCGCCAGTGGTGTGCT Zhang, 2011 N/A
Primer: Sororin_rtPCR REV: TTCAACCAGGAGATCAAACTGC Zhang, 2011 N/A
Primer: GAPDH_rtPCR FWD: ACATCGCTCAGACACCATG Meisenberg, 2015 N/A
Primer: GAPDH_rtPCR REV: TGTAGTTGAGGTCAATGAAGGG Meisenberg, 2015 N/A
Primers for Site Directed Mutagenesis and creation of
Rad21-pEGFP-C1 and STAG2-pmRFP-C1, see Table S4
This paper N/A
Recombinant DNA
Plasmid: Baf180-pEGFP-C3 Kakarougkas et al., 2014 N/A
Plasmid: STAG2-pEGFP-C1 Solomon, 2011 Addgene plasmid: 31972
Plasmid: STAG2-pmRFP-C1 This paper N/A
Plasmid: Rad21-pEGFP-C1 This paper N/A
Plasmid: pEGFP-C1 Gift from Keith Caldecott
(University of Sussex)
N/A
Plasmid: pmRFP-C1 Gift from Keith Caldecott
(University of Sussex)
N/A
Plasmid: Cas9-gRNA Horizon free CRISPR guide program
pcDNA4-GFP-IRES-Puro Gift from Keith Caldecott
(University of Sussex)
N/A
pSpCas9(BB)-2A-Puro (PX459) V2.0 Gift from Helfrid Hochegger
(University of Sussex)
N/A
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METHOD DETAILS
CRISPR-Cas9 U2OS PBRM1 (BAF180) KO
Guide RNA sequences were integrated within an all-in-one Cas9-gRNA vector (Horizon – free CRISPR guide program). A second
plasmid to aid cell selection was pcDNA4-GFP-IRES-Puro, a gift from Prof. Keith Caldecott (University of Sussex, UK). The genomic
sequence targeted for CRISPR-Cas9 disruption in PBRM1 was ATAGAAGAAGTTGGATTCCA. U2OS were co-transfected in a ratio
of 2:1 (Cas9-gRNA: pcDNA4-GFP-IRES-Puro) using TurboFect (R0531, Thermo Fisher Scientific). Transgene expression was
analyzed 24 hr after transfection and cells were put under 1.5 mg/ml puromycin selection for at least 72 hr. Single cells were isolated
and grown for approximately three weeks. Genomic DNA was isolated, and successful clones were determined by SURVEYOR
mutation detection assay (706020, Integrated DNA technologies). Clones were expanded in culture and PBRM1 knockouts were
identified by western blotting using a Baf180 antibody and sequencing (GATC-biotech).
siRNA-Mediated Depletion and Expression Construct Transfection
LNCaP cells were transfected with the indicated siRNA in two rounds separated by 24 hr using Lipofectamine RNAiMAX transfection
reagent (13778150, Invitrogen, Paisley, UK) as permanufacturer’s guidelines. The U2OS cell lines were transfectedwith the indicated
siRNA in two rounds (24 hr apart) on cells in suspension using HiPerfect (301705, QIAGEN, Crawley, UK). Briefly, 12 mL HiPerfect
reagent added to 200 mL Optimem (31985062, GIBCO, Life Technologies, Paisley, UK) was incubated at room temperature for
5 min prior to the addition of siRNA oligonucleotides. The mixture was incubated for 20 min and added to 3.5x105 U2OS cells
suspended in 4 mL media (6 cm dish). Cells were analyzed 72 hr following second transfection. siRNA sources and sequences
are outlined in Table S3.
Transfection Protocol
Plasmid transfection was carried out using Lipofectamine LTX and Plus reagents (15338100, Invitrogen, Paisley, UK) as per manu-
facturer’s guidelines. For micro-irradiation tracking, 6-8 mL LTX reagent and 1-2.5 mL Plus reagent was used to transfect 2-4 mg
plasmid on to 1 3 105 adhered U2OS cells in 2 mL media in a 3.5 cm glass bottom dish (P35G-1.5-14-C, MATEK Corporation).
For the U2OS transcription reporter assay, 8 mL LTX reagent and 2.5 mL Plus reagent was used to transfect 4 mg siRNA resistant
pmRFP-C1-STAG2 plasmids into 3.5 3 105 adhered U2OS 263 IFII cells plated in 4 mL media in a 6 cm dish. The Premo FUCCI
Cell Cycle Sensor BacMam 2.0 system (15 mL; P36237, ThermoFisher Scientific) was used to infect 1 3 105 adhered U2OS cells
plated in 2 mL media in a 3.5 cm glass bottom dish, 16 hr prior to plasmid transfection.
Plasmids
pEGFP-C3-Baf180 was previously described in Kakarougkas et al. (2014) and pEGFP-STAG2-wild-type was obtained fromAddgene
(plasmid # 31972; Solomon et al., 2013). STAG2 cDNA was amplified from the pEGFP-STAG2-wild-type plasmid and inserted
between HindIII and Kpn1 of the pmRFP empty vector. Rad21 cDNA was generated from extracted U2OS mRNA using the
Superscript II First Strand RT-PCR system (11904018, Invitrogen, Paisley, UK) according to the manufacturer’s protocol. cDNA
was amplified and inserted between HindIII and SalI of the pEGFP-C1 empty vector. Both pmRFP-C1 and pEGFP-C1 empty vectors
were a gift from Keith Caldecott (University of Sussex). Primers used are outlined in Tables S4.
Site-Directed Mutagenesis
Site-directed mutagenesis was carried out using QuikChange II Site-Directed Mutagenesis Kit (200523, Agilent) as per manufac-
turer’s guidelines. For the pmRFP-C1-STAG2 plasmid, siRNA resistance to the STAG2-08 sequence was generated by introducing
four silent mutations using 2 sequential primer sets, followed by site-directed mutagenesis to create the STAG2 S202L or V181M
mutations. Selected clones were validated by sequencing. Primers used are outlined in Table S4.
U2OS Transcription Reporter Assay
The U2OS 263 IFII transcription reporter cells (Tang et al., 2013) with siRNA transfection seeded on to coverslips were treated with
1 mMSheild1 (632189, Clontech Laboratories UK Ltd) and 1 mM4-hydroxytamoxifen (4-OHT) (H7904-5MG, Sigma-Aldrich) for 3 hr to
induce mCherry-FokI expression and 1 mg/ml doxycycline hyclate (D9891-G, Sigma-Aldrich) for an additional 3 hr to induce reporter
gene transcription. For samples treated with ATM kinase inhibitor, 10 mM inhibitor (CAS 587871-26-9; sc-202963, Santa Cruz
Biotechnology) was added 1 hr prior to doxycycline hyclate addition. Cells on coverslip were fixed in 4% paraformaldehyde
(15714-5, Electron Microscopy Science), permeabilised for 3 min in 0.2% Triton-X/PBS, washed and mounted on to slides using
VECTASHIELD Antifade Mounting Medium with DAPI (H-1200, Vector Laboratories). Cells were visualized using a Nikon Eclipse
e-400 microscope with 60X oil objective and the number of transcription positive cells were counted from a total of 150 cells per
variable in each independent repeat. For G1/G2 analysis, fixed cells were subject to CENPF (G2 marker) and Cyclin D1 (G1 marker)
immunostaining (as below) using a Cy3 labeled secondary antibody. Slides were subsequently imaged on an Olympus IX73
microscope fitted with a Hamatsu Ocra-Flash 4.0 CMOS camera using the Micromanager ImageJ plugin and a 40X oil objective.
The number of transcription positive cells scored manually from images for n > 100 CENPF or Cyclin D1 positive cells per variable
in each independent repeat.
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EU Incorporation Assay
The Invitrogen Click-iT RNA Alexa Fluor 594 Imaging Kit (C10330, ThermoFisher Scientific) was used to measure RNA synthesis at
laser micro-irradiated sites in the U2OS cell line. Briefly, 13 105 siRNA treated U2OS cells were transferred to 3.5 cm glass bottom
dishes (P35G-1.5-14-C, MatTek Corporation) at the second siRNA hit in suspension as described above. Three days later, the
adhered cells were laser microirradiated with a 405 nm UV-laser at a dose of 0.175 mJ/mm2 following a 30 min incubation in media
containing 10 mg/mL Hoechst 33258 (94403-1ML, Sigma-Aldrich) as described below. Within 10 min of microirradiation, the media
was replaced with media containing the EU component at recommended concentration. After a 45 min incubation, cells were fixed
and the EUClick-IT assay carried out as permanufacturer’s guidelines. Beforemounting, the cells were immunostained for gH2AX as
described below using FITC-labeled anti-mouse secondary antibodies. The coverslips were separated from the MATEK dishes and
mounted on to slides using Vectashield mounting media containing DAPI prior to imaging. The micro-irradiated cells were identified
by gH2AX signal for single plane imaging using a 100X oil objective on a Zeiss microscope fitted with a Hamamatsu Orca ER camera
and Micromanager ImageJ software. ImageJ software was used to analyze the EU intensity profile across the damaged region
(gH2AX positive) using a line tool (69 pixels in length and 15 pixels in width) placed at a 90 angle to damage stripe, centered at
the gH2AX positive region with ends at non-damaged regions. Regions of intense staining (likely corresponding to nucleoli) were
avoided. The EU intensity reads across the line were normalized to each end, and averaged to create the intensity plots. At least
30 cells were analyzed per variable in each independent repeat.
Whole-Cell Extract Preparation and Western Blotting
Cell pellets were lysed for 30min in ice-cold lysis buffer (20mMTris-HCl pH 7.5, 10mMEDTA pH 8.0, 100mMNaCl, 1%Triton X-100)
supplemented with Complete Mini EDTA-free Protease Inhibitor Cocktail (04693159001, Roche Applied Science, Burgess Hill, UK)
and sonicated for 2 cycles 30sON-30sOFF at 4C. The lysate was cleared by centrifugation at 13,000 rpm for 10min and supernatant
collected for protein measurement by Bradford assay and storage at80C. For western blotting, WCE (40 mg) was separated by 8%
SDS-polyacrylamide gel electrophoresis (PAGE) for 2 hr at 125 V followed by transfer onto a Hybond-C Extra Nitrocellulose
membrane (Fisher Scientific UK, Loughborough, UK) for 90 min at 30 V. The membrane was blocked in 5% PBS-milk for 1 hr and
probed overnight with diluted primary antibodies. The membrane was thrice washed in 0.1% TBS-Tween-20, incubated with
secondary antibodies diluted in 5% PBST-milk for 1 hr, washed three times in 0.1% TBS-Tween-20 prior to film development using
in-house ECL reagent. See Table S2 for antibody and dilution information.
gH2AX Foci Analysis
Following siRNA depletion as described above, U2OS cells adhered on coverslips were exposed to 1.5 Gy caesium-137 g-irradiation
(GammaCell 1000, Atomic Energy of Canada Ltd). At indicated time points, cells were analyzed by immunostaining with an antibody
against gH2AX and FITC-labeled secondary as described below. For G1 analysis, cells were also immunostained with Cyclin D1 and
aCy3-labeled secondary. Cells were visualized using a Nikon Eclipse e-400microscopewith 60X objective and the number of gH2AX
foci per cell, or per Cyclin D1-positive (G1) cell, was counted from a total of 36 cells per variable in each independent repeat.
Immunostaining
Sub-confluent cells on coverslips were washed twice in PBS prior to fixing with 4% paraformaldehyde for 20 min, the washed three
times in 1xPBS and permeabilised in 0.2%Triton-X/PBS for 3min. Coverslips werewashed, blocked for 20min in 2%BSA-Fraction V
(A3059-50G, Sigma-Aldrich), and followed by a 1 hr incubation with primary antibody diluted in 2% BSA-Fraction V. The coverslips
were washed three times with 1xPBS, then incubated with labeled secondary antibodies diluted 1:300 in 2% BSA-Fraction V for
45 min. Coverslips were wash three times in 1xPBS, mounted on to slides using DAPI Vectashield (H-1200, Vector Laboratories)
and stored at 4C for further analysis. See Table S2 for antibody and dilution information.
Laser Micro-irradiation
For laser tracking micro-irradiation experiments, 1.5 3 105 U2OS cells seeded in 3.5 cm glass bottom dishes (P35G-1.5-14-C,
MatTek Corporation) were transfectedwith FUCCI cell cyclemarkers 44h prior tomicro-irradiation and expression plasmids 28h prior
to microirradiation as described above. Cells were subject to a 30 min incubation in media containing 10 mg/mL Hoechst 33258
(94403-1ML, Sigma-Aldrich) before micro-irradiating with a 405nm UV laser at a dose of 0.452 mJ/mm2 using a 60X oil objective
on an Olympus 3I Spinning Disk microscope. Micro-irradiation was set to trigger at the second time point and the integrated EMCCD
Evolve camera captured time-lapse images at 10 s intervals for 5 min per cell. A minimum of 20 cells per variable was analyzed
per independent repeat. Quantification was carried out using Spinning Disk Slidebook software.
QRT-PCR Analysis of TMPRSS2 Expression
Prior to 5a-Dihydrotestosterone (DHT) and irradiation (IR) treatment, LNCaP cells were washed twice in serum free RPMI and cultured
for 72 hr in complete RPMI supplemented with 5% charcoal stripped serum instead of 10% FCS. Cells were then irradiated with
10 Gy caesium-137 g-irradiation (GammaCell 1000, Atomic Energy of Canada Ltd) and treated with 300 nM DHT (D-073-1ML,
Sigma-Aldrich) for the times indicated in each figure. RNA was extracted from 1 3 106 LNCaP cells using RNAeasy Mini Kit
(74106, QIAGEN) according to the manufacturer’s protocol. cDNA was synthesized from 1 mg RNA using Superscript II First Strand
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RT-PCR system (11904018, ThermoFisher Scientific) according to the manufacturer’s protocol. Quantitative PCR was performed
using a StepOnePlus Real-Time PCR System (Applied Biosystems) on reactions prepared with Power SYBR green PCR master
mix (4367659, ThermoFisher Scientific) using 2.5% (25 ng) of the cDNA for TMPRSS2 expression analysis. The cyclophilin A gene
was used for normalization. Primers are listed in Table S4.
Assay for IR-Induced TMPRSS2:ERG Translocations by FISH or Quantitative PCR
Prior to 5a-Dihydrotestosterone (DHT) and irradiation (IR) treatment, LNCaP cells werewashed twice in serum free RPMI and cultured
for 72 hr in complete RPMI supplemented with 5% charcoal stripped serum instead of 10% FCS. LNCaP cells were harvested with
trypsin 24 hr after addition of 300 nM DHT (D-073-1ML, Sigma-Aldrich) and treatment with 10 Gy using caesium-137 g-irradiation
(GammaCell 1000, Atomic Energy of Canada Ltd). For quantitative PCR,mRNA and cDNAwere prepared as above and qPCR carried
out using the TMPRSS2:ERG primer set. For FISH analysis, cells were washed in PBS and fixed for 15 min with Carnoy’s Fixative
(3:1 methanol:acetic acid) that was added dropwise to cells while gently vortexing. The suspension was centrifuged at 1500 RPM
for 8 min, the fixation step repeated and the cells resuspended in 30 mL Carnoy’s fixative. Cells were dropped onto a microscope
slide and dried. The slide was rehydrated in 2X SSC (20X SSC: 3 M NaCl, 300 mM trisodium citrate, pH 7.0) for 2 min followed by
dehydration in an ethanol series (70, 80 and 95%) for 2 min each at room temperature. The TMPRSS2/ERG Deletion/Breakapart
Probe mix (LPS 021, Cytocell) and slide were separately incubated for 5 min at 37C before addition of the probe mix to the slide,
addition of a coverslip and sealing with rubber glue. The slide was heated at 75C for 5 min before overnight incubation at 37C.
The coverslip was removed, the slide washed in 0.4X SSC for 2 min at 72C and then in 2X SSC with 0.05% Tween-20 for 30 s at
room temperature. The coverslip was mounted on slides using DAPI and imaged with a 40X objective on an Olympus IX71 micro-
scope fitted with a CoolSNAP HQ2 camera and Micromanager ImageJ software. A total of 50 imaged cells per variable were scored
manually as unrearranged or rearranged (example images in Figure 5E).
Assay for CRISPR-Cas9-Induced TMPRSS2:ERG Translocations
CRISPR guide RNA sequences against the TMPRSS2 gene (Primer pair TMPRSS2-CR-3) and the ERG gene (Primer pair ERG-CR-2)
(from Li et al., 2018) were cloned in to the Cas9-empty plasmid (pSpCas9(BB)-2A-Puro (PX459) V2.0 plasmid (Ran, 2013) using BbsI-
HF (NEB; R3539S) restriction enzyme to create Cas9-TMPRSS2 and Cas9-ERG plasmids. LNCaP cells subjected to the 2-hit siRNA
depletion in CSS-RPMI media were trypsinised on day 3, counted and 4x10^5 cells transfected with either 6mg Cas9-empty plasmid
or 3mg each for plasmids Cas9-TMPRSS2 and Cas9-ERG in CSS RPMI media with or without 300nM DHT. The media was replaced
with or without 300nM DHT 24hr later and cells harvested at 72hr for analysis by QRT-PCR using TMPRSS2-ERG translocation
primers, as above.
Cell-Cycle Synchronization and FACS Analysis
siRNA treated U2OS cells were synchronized in G1 phase using a double thymidine block. Specifically, 7.53 105 siRNA transfected
U2OS cells were treated with 2.5 mM thymidine in media for 19 hr. Cells were washed twice with PBS and incubated in media for 9h,
prior to the addition of 2.5 mM thymidine for 16 hr to synchronize cells in G1 (this time point is referred to as ‘0 hr’ in figure S6A). For
fluorescence-activated cell sorting (FACS) analysis of cell cycle profile, cells were trypsinized, washed twice in ice-cold PBS and
resuspended in 0.5 mL 1X PBS. Cells were fixed by gently vortexing while adding 4.5 mL ice-cold 70% ethanol drop-wise followed
by 30 min incubation at 4C. Fixed cells were washed twice in 1X PBS and resuspended in 0.5 mL Staining Solution (0.1% Triton
X-100, 10 mg/mL propidium iodide (P3566, ThermoFisher Scientific), 100 mg/mL RNase A (R5503-100MG, Sigma-Aldrich)) and incu-
bated for 30 min in the dark at room temperature. Cells were analyzed on a BD LSR II Flow Cytometer (BD Biosciences) and profiles
generated using FlowJo v10.1 software.
Exome Sequencing Analysis
U2OS cells were subject to siRNA depletion and double thymidine block to synchronize cells in G1 (as described above). After 24 hr,
one set of each siRNA treated sample was irradiated with 10 Gy using caesium-137 g-irradiation (GammaCell 1000, Atomic Energy of
Canada Ltd, Canada). One hour prior to irradiation, one set of the SA2-depleted cells were treated with 75 mMDRB. All samples were
collected 6h after irradiation. Genomic DNA was isolated using Nucleospin Tissue kit (740952.5, Machery-Nagel). Exome capture
was performed, and the library was subjected to paired-end sequencing using a HiSeq2500 system (Illumina) at the Tumor Profiling
Unit (Institute of Cancer Research) to a median depth of 100X per sample.
BWA (version 0.7.5a) was used to align reads to the human reference genome (GRCh37). PCR duplicates were removed prior to
further processing and variant detection. Variants were called using Genome Analysis Tool Kit (GATK; version 2.7-2) and MuTect
(version 1.1.4) Broad Best Practices Pipeline using standard settings, and the structural rearrangements were identified using Delly2.
The U2OS cell line was sequenced in parallel so that changes in the experimental samples that were shared with the parental U2OS
sample were removed.
Analysis of Cancer Samples
To investigate the difference in mutational patterns in SA2 competent and SA2 deficient tumors, mutational fingerprints for two
groups of patients were generated (Polak et al., 2017) using mutational data from whole genome screens annotated in the COSMIC
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database https://cancer.sanger.ac.uk (Forbes et al., 2017). One group included samples from 336 bladder cancer patients that did
not exhibit a SA2 mutation and the other group included samples from 38 bladder cancer patients with a SA2 mutation.
For both groups of samples their mutational fingerprints were decomposed using a non-negative matrix factorisation to
produce 5 signatures. Decomposition was performed using the Brunet method (Brunet et al., 2004) through the NMF library in
R3.4.0. The resulting signatures were compared to those published in COSMIC using a correlation matrix produced again in R using
the Pearson’s correlation method.
To determine whether or not there is a link between large-scale chromosomal alterations and inactivating mutations in SA2, we
used copy number variance data. We first explored whether or not there is a link between large-scale chromosomal rearrangements
and CNV using COSMIC CNV data for an exome screen on breast cancers where information on chromosomal rearrangements is
available. This included 571 samples with documented structural changes and 1175 changes that did not. There were 22-fold
more genes affected by CNV changes in samples with structural changes than in samples without (12,505 versus 571). Using a
chi squared test, the chance of this happening with independent distributions has a vanishing p value. Therefore, we used CNV
data to investigate whether SA2-deficient cancer samples have a greater number of large-scale chromosome rearrangements
than SA2-proficient cancer samples. Copy number variance data were available for 409 TCGA bladder cancer samples from
the genomic data commons and, as before this was combined with matching somatic mutation data from COSMIC. Copy number
variance data were thenmapped to gene positions and the segment mean calculated in order to identify for each gene whether or not
it had changed significantly. Cutoffs of 0.2 and 0.2 were used in accordance with common practice (Laddha et al., 2014). Our null
hypothesis was that there is no correlation between the mutation status of SA2 in a sample and the number of genes that had a
changed segment mean. Samples were then split into two groups, 11 where SA2 had a non-synonymous mutation and 398 where
they did not. A chi-square test showed that our null hypothesis has a vanishing chance of being correct (p = 0.0).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical details of experiments (numbers of biological replicates and use of standard deviation or standard error) are included in the
Figure legends and/or the specific methods section. Significance for Student’s t test or Chi Squared analyses are indicated in figures
as * = p < 0.05, ** = p < 0.01 and *** = p < 0.001.
DATA AND SOFTWARE AVAILABILITY
Raw data files have been deposited in Mendeley Data (https://doi.org/10.17632/4h486ty62f.1).
The accession number for the exome sequencing data reported in this paper is NCBI SRA: SAMN08226046.
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